14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.00 $25.47 Thursday, 2nd May 2024 DCPH stock ended at $25.38. This is 0.0789% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 0.493% from a day low at $25.35 to a day high of $25.47.
90 days $13.86 $25.47
52 weeks $9.90 $25.47

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
Aug 22, 2023 $14.90 $15.07 $14.73 $15.02 290 518
Aug 21, 2023 $14.59 $15.10 $14.42 $14.91 434 900
Aug 18, 2023 $14.08 $14.85 $14.08 $14.61 284 343
Aug 17, 2023 $14.59 $14.64 $14.15 $14.22 345 408
Aug 16, 2023 $15.42 $15.58 $14.43 $14.55 462 156
Aug 15, 2023 $15.21 $15.51 $14.82 $15.48 385 320
Aug 14, 2023 $14.99 $15.61 $14.67 $15.24 510 308
Aug 11, 2023 $15.27 $16.43 $15.02 $15.15 496 214
Aug 10, 2023 $14.50 $15.52 $14.34 $15.32 1 736 962
Aug 09, 2023 $13.58 $13.92 $13.28 $13.74 380 164
Aug 08, 2023 $12.87 $13.07 $12.80 $12.94 337 326
Aug 07, 2023 $13.14 $13.22 $12.79 $12.82 398 964
Aug 04, 2023 $13.14 $13.31 $12.85 $13.08 390 626
Aug 03, 2023 $13.09 $13.46 $13.09 $13.17 288 499
Aug 02, 2023 $13.42 $13.57 $13.05 $13.12 349 404
Aug 01, 2023 $13.53 $13.65 $13.37 $13.59 271 409
Jul 31, 2023 $13.25 $13.55 $13.25 $13.52 232 621
Jul 28, 2023 $13.10 $13.51 $13.05 $13.26 310 979
Jul 27, 2023 $13.20 $13.20 $12.82 $13.00 368 506
Jul 26, 2023 $13.17 $13.35 $13.00 $13.15 292 267
Jul 25, 2023 $13.32 $13.43 $13.05 $13.16 229 544
Jul 24, 2023 $13.68 $13.71 $13.16 $13.32 374 426
Jul 21, 2023 $13.70 $13.98 $13.66 $13.71 266 042
Jul 20, 2023 $13.82 $13.83 $13.37 $13.61 317 603
Jul 19, 2023 $13.92 $13.95 $13.70 $13.81 266 337
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT